Phase II study of trifluridine/tipiracil (TAS-102) plus irinotecan in combination with bevacizumab as a second‐line therapy for patients with metastatic colorectal cancer.
Final analysis of fixed-duration ibrutinib + venetoclax for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in the phase 2 CAPTIVATE study. Preliminary safety and efficacy data of ...
MedPage Today on MSN
Liver disease medication linked to lower cancer risks
Treatment with ursodeoxycholic acid (UDCA) in adults with primary biliary cholangitis (PBC) was associated with significantly lower risks of certain cancers, a retrospective propensity-score matched ...
MedPage Today on MSN
Incretin therapies after bariatric surgery linked to lower risk of alcohol disorder
Treatment with incretin-based weight-loss medications, like GLP-1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback